1 active not recruiting, 1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Thymus Carcinoma: new trials by email Literature Review of Thymus Carcinoma trials Research Report on Thymus Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers Computed Tomography, Fludeoxyglucose F-18, Gallium Ga 68 FAPi-46 - Anal Carcinoma, Bladder Carcinoma | Phase 1 | Active not recruiting | Jonsson Comprehensive Cancer Center | 30 | 2025-08-01 | 2026-10-20 |
| Ivonescimab for the Treatment of Thymic Cancer Biopsy Procedure, Biospecimen Collection, Computed Tomography - Thymus Carcinoma | Phase 2 | Recruiting | Jonsson Comprehensive Cancer Center | 25 | 2025-07-15 | 2026-10-05 |
Adrenal Gland Neoplasms (1) · Anus Neoplasms (1) · Brain Neoplasms (1) · Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Medullary (1) · Carcinoma, Transitional Cell (1) · Cholangiocarcinoma (1) · Colorectal Neoplasms (1) · Esophageal Neoplasms (1) · Lung Neoplasms (1) · Neuroendocrine Tumors (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Penile Neoplasms (1)
Adenocarcinoma (1) · Adnexal Diseases (1) · Adrenal Gland Diseases (1) · Anus Diseases (1) · Brain Diseases (1) · Breast Diseases (1) · Carcinoma (1) · Carcinoma, Neuroendocrine (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1)
Magnetic Resonance Spectroscopy (2) · Biopsy (1) · FAPI-46 (1) · Fluorodeoxyglucose F18 (1) · Specimen Handling (1)
Jonsson Comprehensive Cancer Center (2)
United States (2)
Jeremie Calais (1) · Jonathan W Goldman (1)